4//SEC Filing
BOLT WILLIAM J 4
Accession 0001179110-18-006500
CIK 0000815094other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:21 PM ET
Size
37.5 KB
Accession
0001179110-18-006500
Insider Transaction Report
Form 4
ABIOMED INCABMD
BOLT WILLIAM J
SVP, QA and Regulatory Affairs
Transactions
- Exercise/Conversion
Common Stock, $.01 par
2018-05-07$99.62/sh+1,666$165,967→ 66,414 total - Sale
Common Stock, $.01 par
2018-05-07$347.02/sh−5,408$1,876,680→ 70,806 total - Sale
Common Stock, $.01 par
2018-05-07$345.21/sh−1,545$533,342→ 78,869 total - Sale
Common Stock, $.01 par
2018-05-07$346.20/sh−2,655$919,156→ 76,214 total - Sale
Common Stock, $.01 par
2018-05-07$350.94/sh−1,368$480,085→ 57,824 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-07−4,000→ 2,000 totalExercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (4,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-07−1,666→ 3,334 totalExercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (1,666 underlying) - Exercise/Conversion
Common Stock, $.01 par
2018-05-07$66.25/sh+4,000$265,000→ 70,414 total - Exercise/Conversion
Common Stock, $.01 par
2018-05-07$21.55/sh+5,000$107,750→ 75,414 total - Sale
Common Stock, $.01 par
2018-05-07$349.06/sh−7,901$2,757,886→ 60,192 total - Sale
Common Stock, $.01 par
2018-05-07$350.01/sh−1,000$350,007→ 59,192 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-07−5,000→ 0 totalExercise: $23.15From: 2014-05-14Exp: 2023-05-14→ Common stock (5,000 underlying) - Exercise/Conversion
Common Stock, $.01 par
2018-05-07$23.15/sh+5,000$115,750→ 80,414 total - Sale
Common Stock, $.01 par
2018-05-07$347.98/sh−2,713$944,072→ 68,093 total - Sale
Common Stock, $.01 par
2018-05-07$352.16/sh−200$70,432→ 57,624 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-07−5,000→ 0 totalExercise: $21.55From: 2015-05-14Exp: 2024-05-14→ Common Stock (5,000 underlying)
Holdings
- 3,000
Stock Option (Right to Buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying)
Footnotes (14)
- [F1]These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- [F10]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $347.5600 and $348.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F11]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $348.5600 and $349.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F12]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $349.6600 and $350.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F13]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $350.7300 and $351.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F14]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $351.9700 and $352.3500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F2]Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F3]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F4]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F5]Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- [F6]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F7]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.5600 and $345.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F8]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.9500 and $346.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F9]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.5600 and $347.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001199632
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:21 PM ET
- Size
- 37.5 KB